February 2013 - Volume 33 - Issue 1
pp: 1-148


Association of a Functional Polymorphism in Neuropeptide Y With Antipsychotic-Induced Weight Gain in Schizophrenia Patients

Tiwari, Arun K.; Brandl, Eva J.; Weber, Caroline; More

Journal of Clinical Psychopharmacology. 33(1):11-17, February 2013.

Atomoxetine Treatment of Attention-Deficit/Hyperactivity Disorder in Young Adults With Assessment of Functional Outcomes: A Randomized, Double-Blind, Placebo-Controlled Clinical...

Durell, Todd M.; Adler, Lenard A.; Williams, Dave W.; More

Journal of Clinical Psychopharmacology. 33(1):45-54, February 2013.




Leptin Plasma Concentrations Increase During Antidepressant Treatment With Amitriptyline and Mirtazapine, But Not Paroxetine and Venlafaxine: Leptin Resistance Mediated by...

Schilling, Claudia; Gilles, Maria; Blum, Werner F.; More

Journal of Clinical Psychopharmacology. 33(1):99-103, February 2013.

A Randomized, Controlled, Pilot Trial of Methylphenidate and Cognitive-Behavioral Group Therapy for Cocaine Dependence in Heroin Prescription

Dürsteler-MacFarland, Kenneth M.; Farronato, Nadine S.; Strasser, Johannes; More

Journal of Clinical Psychopharmacology. 33(1):104-108, February 2013.

Assessing the Sources of Unreliability (Rater, Subject, Time-Point) in a Failed Clinical Trial Using Items of the Positive and Negative Syndrome Scale (PANSS)

Khan, Anzalee; Yavorsky, William Christian; Liechti, Stacy; More

Journal of Clinical Psychopharmacology. 33(1):109-117, February 2013.


Effects of the Cannabinoid-1 Receptor Antagonist/Inverse Agonist Rimonabant on Satiety Signaling in Overweight People with Schizophrenia: A Randomized, Double-Blind, Pilot Study

Warren, Kimberly R.; Buchanan, Robert W.; Feldman, Stephanie; More

Journal of Clinical Psychopharmacology. 33(1):118-120, February 2013.

Eating-Behavior Changes Associated With Antipsychotic Medications in Patients With Schizophrenia as Measured by the Drug-Related Eating Behavior Questionnaire

Ryu, Seunghyong; Nam, Hee Jung; Oh, Sohee; More

Journal of Clinical Psychopharmacology. 33(1):120-122, February 2013.

1 2 3 4 5